BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal second-quarter earnings of $162.6 million. The Boston-based company said it had net income of $1.35 per share. Earnings, ...

PTC Inc. closed 24.34% short of its 52-week high of $203.09, which the company achieved on December 12th.

April 30 - Industrial software maker PTC (PTC.O), opens new tab raised its annual revenue forecast and beat Wall Street estimates for second-quarter revenue on Wednesday, driven by resilient ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) ...

The Board of Directors of PTC India Limited at its meeting held today i.e. 26th April, 2025 have considered and approved the ...

(1) In Q1'24, we acquired pure-systems for $93 million, net of cash acquired. (2) In Q2'25, net repayments include borrowings on our credit facility revolver to fund the $500 million bond ...

In this article, we are going to take a look at where PTC Inc. (NASDAQ:PTC) stands against other best augmented reality stocks to buy according to hedge funds. According to a report by Mordor ...

Mining major Hindustan Zinc expects to further lower its cost of production by $25-30 per tonne as coal prices continue to soften, offering some cushion against a volatile global pricing ...

Hindustan Zinc Ltd, India’s only silver producer, has been awarded the prestigious title of the Largest Integrated Silver Manufacturer 2024 at the 3rd edition of the India Silver Conference 2025 ...

Hindustan Zinc CEO and Whole Time Director, Arun Misra, says he expects global prices of zinc to stay between $2,600 and $2,750 per ton in the next two to three quarters, and then climb to $2,800 ...

07-Jun-24 19-Sep-24 19-Sep-24 7.8 Rs.7.8000 per share(78%)Final Dividend 25-Aug-23-20-Sep-23 7.8 Rs.7.8000 per share(78%)Final Dividend 08-Dec-22-15-Dec-22 5.8 Rs.5.8000 per share(58%)Final Dividend ...

More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved ...